Myc Downregulation by Transforming Growth Factor β Required for Activation of the p15^Ink4b G₁ Arrest Pathway

REFERENCES

• Alevizopoulos, K., J. Vlach, S. Hennecke, and J. Amati 1997. Cyclin E and c-Myc promote cell proliferation in the presence of p16Ink4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16:5322–5333.
   PubMedGoogle Scholar
• Alexandrow, M. G., and J. Moses 1995. Transforming growth factor β and cell cycle regulation. Cancer Res. 55:1452–1457.
   PubMed Web of Science ®Google Scholar
• Amati, B., K. Alevizopoulos, and J. Vlach 1998. Myc and the cell cycle. Front. Biosci. 3:250–268.
   PubMed Web of Science ®Google Scholar
• Attisano, L., J. Cárcamo, F. Ventura, F. M. B. Weis, J. Massagué, and J. Wrana 1993. Identification of human Activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671–680.
   PubMed Web of Science ®Google Scholar
• Blain, S. W., E. Montalvo, and J. Massague 1997. Differential interaction of the cyclin-dependent kinase (cdk) inhibitor p27 with cyclin A-cdk2 and cyclin D2-cdk4. J. Biol. Chem. 272:25863–25872.
   PubMed Web of Science ®Google Scholar
• Bouchard, C., P. Staller, and J. Eilers 1998. Control of cell proliferation by Myc. Trends Cell Biol. 8:202–206.
   PubMed Web of Science ®Google Scholar
• Brotherton, D. H., V. Dhanaraj, S. Wick, L. Brizuela, P. J. Domaille, E. Volyanik, W. Wu, E. Parisini, B. O. Smith, S. J. Archer, M. Serrano, S. L. Brenner, T. L. Blundell, and J. Laue 1998. Crystal structure of the complex of the cyclin D-dependent kinase cdk6 bound to the cell-cycle inhibitor p19Ink4D. Nature 395:244–250.
   PubMed Web of Science ®Google Scholar
• Cherif, D., M. Le Coniat, H. G. Suarez, A. Bernheim, and J. Berger 1988. Chromosomal localization of amplified c-myc in a human colon adenocarcinoma cell line with a biotinylated probe. Cancer Genet. Cytogenet. 33:245–249.
   PubMedGoogle Scholar
• Dang, C. V. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1–11.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and J. Wang 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanisms. Proc. Natl. Acad. Sci. USA 92:5545–5549.
   PubMed Web of Science ®Google Scholar
• Derynck, R., W. M. Gelbart, R. M. Harland, C.-H. Heldin, S. E. Kern, J. Massagué, D. A. Melton, M. Mlodzik, and J. Padgett 1996. Nomenclature: vertebrate mediators of TGFβ family signals. Cell 87:173.
   PubMedGoogle Scholar
• Evan, G. I., L. Brown, M. Whyte, and J. Harrington 1995. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7:825–834.
   PubMed Web of Science ®Google Scholar
• Gossen, M., and J. Bujard 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547–5551.
   PubMed Web of Science ®Google Scholar
• Grandori, C., and J. Eisenman 1997. Myc target genes. Trends Biochem. Sci. 22:177–181.
   PubMedGoogle Scholar
• Hannon, G. J., and J. Beach 1994. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257–261.
   PubMed Web of Science ®Google Scholar
• Harlow, E., D. Lane 1988. Antibodies: a laboratory handbook. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Heldin, C.-H., K. Miyazono, and J. ten Dijke 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471.
   PubMed Web of Science ®Google Scholar
• Henriksson, M., and J. Luscher 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:109–182.
   PubMed Web of Science ®Google Scholar
• Hua, X., X. Liu, D. O. Ansari, and J. Lodish 1998. Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 12:3084–3095.
   PubMed Web of Science ®Google Scholar
• Iavarone, A., and J. Massagué 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387:417–422.
   PubMedGoogle Scholar
• Khaira, P., C. D. James, and J. Leffak 1998. Amplification of the translocated c-myc genes in three Burkitt lymphoma cell lines. Gene 211:101–108.
   PubMedGoogle Scholar
• Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massagué 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260:536–539.
   PubMed Web of Science ®Google Scholar
• Kretzschmar, M., J. Doody, and J. Massagué 1997. Opposing BMP and EGF signalling pathways converge on the TGFβ family mediator Smad1. Nature 389:618–622.
   PubMed Web of Science ®Google Scholar
• Kretzschmar, M., J. Doody, I. Timokhina, and J. Massagué 1999. A mechanism of repression of TGF-β/Smad signaling by oncogenic Ras. Genes Dev. 13:804–816.
   PubMed Web of Science ®Google Scholar
• Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massagué 1990. Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185.
   PubMed Web of Science ®Google Scholar
• Lehman, T. A., R. Modali, P. Boukamp, J. Stanek, W. P. Bennet, J. A. Welsh, R. A. Metcalf, M. R. Stampfer, N. Fusenig, E. M. Rogan, and J. Harris 1993. p53 Mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833–839.
   PubMed Web of Science ®Google Scholar
• Leone, G., J. DeGregori, R. Sears, L. Jokoi, and J. Nevins 1997. Myc and Ras collaborate in inducing accumulation of active cyclinE/cdk2 and E2F. Nature 387:422–426.
   PubMed Web of Science ®Google Scholar
• Li, J.-M., M. A. Nichols, S. Chandrasekharan, Y. Xiong, and J. Wang 1995. Transforming growth factor ß activates the promoter of cyclin-dependent kinase inhibitor p15Ink4B through an Sp1 consensus site. J. Biol. Chem. 270:26750–26753.
   PubMed Web of Science ®Google Scholar
• Li, L., C. Nerlov, G. Prendergast, D. MacGregor, and J. Ziff 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13:4070–4079.
   PubMedGoogle Scholar
• Mahony, D., D. A. Parry, and J. Lees 1998. Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene 16:603–611.
   PubMed Web of Science ®Google Scholar
• Malliri, A., W. A. Yeudall, M. Nikolic, D. H. Crouch, E. K. Parkinson, and J. Ozanne 1996. Sensitivity to transforming growth factor beta-1 induced growth arrest is common in human squamous cell carcinoma cell lines: c-Myc downregulation and p21Waf1 induction are important early events. Cell Growth Differ. 7:1291–1304.
   PubMedGoogle Scholar
• Massagué, J. 1998. TGFβ signal transduction. Annu. Rev. Biochem. 67:753–791.
   PubMed Web of Science ®Google Scholar
• Massagué, J. 1990. The transforming growth factor-ß1 family. Annu. Rev. Cell Biol. 6:597–641.
   PubMedGoogle Scholar
• Masuda, A., M. Kondo, T. Saito, Y. Yatabe, T. Kobayashi, M. Okamoto, M. Suyama, T. Takahashi, and J. Takahashi 1997. Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor beta1. Cancer Res. 57:4898–4904.
   PubMedGoogle Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Kato 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
   PubMed Web of Science ®Google Scholar
• McConnell, B. B., F. J. Gregory, F. J. Stott, E. Hara, and J. Peters 1999. Induced expression of p16Ink4a inhibits both cdk4- and cdk2-associated kinase activity by reassortment of cyclin-cdk inhibitor complexes. Mol. Cell. Biol. 19:1981–1989.
   PubMed Web of Science ®Google Scholar
• Moustakas, A., and J. Kardassis 1998. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95:6733–6738.
   PubMed Web of Science ®Google Scholar
• Müller, D., C. Bouchard, B. Rudolph, P. Steiner, I. Stuckmann, R. Saffrich, W. Ansorge, W. Huttner, and J. Eilers 1997. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 15:2561–2576.
   PubMed Web of Science ®Google Scholar
• Nakao, A., M. Afrakhte, A. Morén, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N. E. Heldin, C. H. Heldin, and J. ten Dijke 1997. Identification of Smad7, a TGFß-inducible antagonist of TGF-ß signaling. Nature 389:631–635.
   PubMed Web of Science ®Google Scholar
• Parry, D., D. Mahony, K. Wills, and J. Lees 1999. Cyclin D-cdk subunit arrangement is dependent on the availability of competing Ink4 and p21 class inhibitors. Mol. Cell. Biol. 19:1775–1783.
   PubMed Web of Science ®Google Scholar
• Perez-Roger, I., D. L. C. Solomon, A. Sewing, and J. Land 1997. Myc activation of cyclin E/cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene 14:2373–2381.
   PubMed Web of Science ®Google Scholar
• Philipp, A., A. Schneider, I. Vasrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and J. Eilers 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14:4032–4043.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., R. W. Stein, E. Moran, P. Yacuik, R. Schlegel, R. M. Lyons, R. M. Pittelkow, K. Münger, P. M. Howley, and J. Moses 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domeins. Cell 61:777–785.
   PubMed Web of Science ®Google Scholar
• Polyak, K. 1996. Negative regulation of cell growth by TGF-β. Biochim. Biophys. Acta 1242:185–199.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J.-Y. Kato, M. J. Solomon, C. J. Sherr, J. Massagué, J. M. Roberts, and J. Koff 1994. p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-ß and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M.-H. Lee, H. Erdjument-Bromage, A. Koff, P. Tempst, J. M. Roberts, and J. Massagué 1994. Cloning of p27Kip1 a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66.
   PubMed Web of Science ®Google Scholar
• Reynisdóttir, I., and J. Massagué 1997. The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492–503.
   PubMed Web of Science ®Google Scholar
• Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831–1845.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., M. B. Sporn 1990. The transforming growth factor-betas. Springer-Verlag KG, Heidelberg, Germany.
   Google Scholar
• Russo, A. A., L. Tong, J.-O. Lee, P. D. Jeffrey, and J. Pavletich 1998. Structural basis for inhibition of the cyclin-dependent kinase cdk6 by the tumour suppressor p16Ink4a. Nature 395:237–243.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. The ins and outs of Rb: coupling gene expression to the cell cycle clock. Trends Cell Biol. 4:15–18.
   PubMedGoogle Scholar
• Sherr, C. J., and J. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Song, C.-Z., T. E. Siok, and J. Gelehrter 1998. Smad4/DPC4 and Smad3 mediate transforming growth factor-β (TGF-β) signaling through direct binding to a novel TGF-β-responsive element in human plasminogen activator inhibitor-1 protein. J. Biol. Chem. 273:29287–29290.
   PubMedGoogle Scholar
• Soos, T. J., H. Kiyokawa, J. S. Yan, M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and J. Koff 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135–146.
   PubMedGoogle Scholar
• Steiner, P., A. Philipp, J. Lukas, D. Godden-Kent, M. Pagano, S. Mittnacht, J. Bartek, and J. Eilers 1995. Identification of a myc-dependent step during formation of active G1 cyclin-cdk complexes. EMBO J. 14:4814–4826.
   PubMed Web of Science ®Google Scholar
• Stepanova, L., X. Leng, S. G. Parker, and J. Harper 1996. Mammalian p50cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes cdk4. Genes Dev. 10:1491–1502.
   PubMed Web of Science ®Google Scholar
• Sun, P., P. Dong, K. Dai, G. J. Hannon, and J. Beach 1998. p53-independent role of MDM-2 in TGF-β resistance. Science 282:2270–2272.
   PubMed Web of Science ®Google Scholar
• Tonini, G. P., D. Radzioch, A. Gronberg, M. Clayton, E. Blasi, G. Benetton, and J. Varesio 1987. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562. Cancer Res. 47:4544–4547.
   PubMedGoogle Scholar
• Ulloa, L., J. Doody, and J. Massagué 1999. Inhibition of transforming growth factor β/SMAD signalling by the interferon-γ/STAT pathway. Nature 397:710–713.
   PubMed Web of Science ®Google Scholar
• Vlach, J., S. Hennecke, K. Alevizopoulos, D. Conti, and J. Amati 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15:6595–6604.
   PubMed Web of Science ®Google Scholar
• Zentella, A., F. M. B. Weis, D. A. Ralph, M. Laiho, and J. Massagué 1991. Early gene responses to transforming growth factor β in cells lacking growth suppressive RB function. Mol. Cell. Biol. 11:4952–4958.
   PubMedGoogle Scholar